Your Article Summary
See Latest ArticlesRecommendations on the use of 18F-FDG PET in oncology
The Journal of Nuclear Medicine, 03/10/08
Fletcher JW et al. - In a trial to develop recommendations on use of 18F-FDG PET in breast, colorectal, esophageal, head and neck, lung, pancreatic, and thyroid cancer; lymphoma, melanoma, and sarcoma; and unknown primary tumor, it was recommended that 18F-FDG PET should be used as an imaging tool in addition to conventional radiologic methods such as CT or MRI
Methods- A search was performed to identify all published randomized controlled trials and systematic reviews in the literature
- An additional search was performed to identify relevant unpublished systematic reviews
- Publications comprised both retrospective and prospective studies of varied methodologic quality
- Anticipated consequences of false-positive and false-negative tests when evaluating clinical usefulness, and impact of 18F-FDG PET on management of cancer pts, were also reviewed
- 18F-FDG PET should be used as an imaging tool in addition to conventional radiologic methods such as CT or MRI
- Any positive finding that could lead to a clinically significant change in pt management should be confirmed by subsequent histopathologic examination because of the risk of false-positive results
- 18F-FDG PET should be used in the appropriate clinical setting for the diagnosis of head and neck, lung, or pancreatic cancer and for unknown primary tumor
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effectiveness of a Home Care Nursing Program in the Symptom Management of Patients With Colorectal and Breast Cancer Receiving Oral Chemotherapy: A Randomized, Controlled Trial
Journal of Clinical Oncology, 12/04/09
Adjuvant Phytotherapy in the Treatment of Cervical Cancer: A Systematic Review and Meta-Analysis
Journal of Alternative and Complementary Medicine, 12/04/09
Preimplantation genetic diagnosis for haematologic conditions
Current Opinion in Pediatrics, 12/04/09